JPRN-UMIN000030717招募中2 期
The phase 2 study of neoadjuvant chemotherapy of gemcitabine+nab-paclitaxel+S-1 for patients with biological borderline resectable pancreatic cancer. - The phase 2 study of neoadjuvant chemotherapy of gemcitabine+nab-paclitaxel+S-1 for patients with biological borderline resectable pancreatic cancer.
Department of gastrointestinal Surgery, Hiroshima University Hospital0 个研究点目标入组 50 人开始时间: 2018年4月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Severe allergy for protcol drugs 2.Histly of active malignant disease within 5 years 3. Active infectious disease 4. >Geade2 of neuropahty 5. Ileus 6. Active interstitional pneumonia 7. Uncontrolable ascites and pleural effusion 8.Uncontrolable diabetes 9.Uncontrolable heart diseases 10.Histry of sevese neurological sidease 11.Pregnancy or possibility of pregnancy 12.Others who were judged to be not appropriate for participation to this clinicalrial by attending physician
研究者
相似试验
招募中
2 期
The phase 2 study of neoadjuvant chemotherapy of GAS for biological borderline resectable pancreatic cancer.Biological borderline resectable pancreatic cancerJPRN-jRCTs061180009emura Kenichiro50
已完成
2 期
Phase II study of Neoadjuvant chemotherapy with Gemcitabine and S1 (GS therapy) for resectable pancreatic carcinoma (NAC GS2+2)resectable pancreatic cancerJPRN-UMIN000009070EXTSURG35
已完成
2 期
Phase II study of Neoadjuvant chemotherapy with Gemcitabine and S1 (GS therapy) for resectable pancreatic carcinoma (NAC GS3)resectable pancreatic cancerJPRN-UMIN000003402Miyagi HBPCOG35
已完成
2 期
Phase II study of Neoadjuvant chemotherapy with Gemcitabine and S1 for resectable pancreatic carcinomaresectable pancreatic cancerJPRN-UMIN000004148Study group of preoperative therapy for pancreatic cancer (Prep)80
招募中
2 期
Phase II study of the neoadjuvant chemotherapy of GEM/nab-PTX for biological borderline-resectable pancreatic cancerC535836pancreatic cancerJPRN-jRCT1041230068Ebata Tomoki50